NNOX logo

NANO-X IMAGING LTD

NNOXNASDAQ
πŸ† #3536 by market capUS Equity
$1.11β–² $0.05 (+4.23%)
πŸŒ… Pre-market$1.12β–² 0.45%Regular close Β· extended-hours price shown
1hβ€”
24hβ–² 4.2%
7dβ–² 9.4%
14dβ–² 26.2%
30dβ–² 5.7%
1yβ–Ό 75.1%
🏦Market Cap
$77M
Small Cap
πŸ“ˆRevenue Growth (YoY)
-9.6%
Declining
πŸ“ŠGross Margin
-84.9%
Thin
πŸ’΅FCF Margin
β€”
βš–οΈP/S Ratio
5.1x
Fair
Otter Score
57
Weak

Trading Snapshot

Day Range
$1.10 – $1.12
52-Week Range
$0.73 – $4.88
Volume
$2.76B
Avg Volume
$3.08B
Shares Outstanding
69.6M
Next Earnings
Oct 16, 2026

Fundamentals Snapshot

Annual Revenue
$13M
Last Q Revenue
$4M
P/E Ratio
β€”
P/S Ratio
5.1x
EPS (TTM)
$-1.15
Dividend Yield
β€”

Why Investors Own NNOX

  • βœ“High-growth profile β€” revenue up -4.2% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 51% gross margin and 19% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$13Mβ–Ό βˆ’0.9% YoY
Gross Margin (TTM)
51.3%β–² +3.2% YoY
Operating Income (TTM)
$3Mβ–Ό βˆ’0.9% YoY
Free Cash Flow (TTM)
$3Mβ–Ό βˆ’0.9% YoY

About NANO-X IMAGING LTD

Nano-X Imaging Ltd. specializes in developing a commercial-grade tomographic imaging device that incorporates an innovative digital X-ray source, which leverages a digital micro-electro-mechanical systems (MEMS) semiconductor cathode. Beyond its hardware focus, the company also delivers teleradiology services and creates artificial intelligence (AI) applications tailored for practical use in medical imaging. Its core offerings include the Nanox.ARC, a prototype medical imaging system that integrates its proprietary digital X-ray technology, and Nanox.CLOUD, a complementary cloud-based software platform envisioned to facilitate medical screening as a service. Nano-X also operates Nanox.MARKETPLACE, a platform designed to connect imaging facilities and customers with radiologists for efficient remote interpretation of medical scans. Additionally, the company provides AI-driven software solutions to a wide range of healthcare entities, including hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers. These solutions are designed to analyze data from existing computed tomography (CT) scans to identify or predict undiagnosed or underdiagnosed medical conditions, such as osteoporosis and cardiovascular disease. Nano-X further offers Teleradiology Services, delivering remote imaging interpretation to radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities, and multi-specialty physician groups. Founded in 2011, Nano-X Imaging Ltd. is headquartered in Neve Ilan, Israel.

🦦

Otter Score Breakdown

β“˜
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
Overall Score
Weak
57/100

Analyst Ratings

β“˜
Consensus
Buy
9 analysts
Strong Buy3
Buy4
Hold2
Sell0
Strong Sell0
Ratings as of Aug 2026

Latest News & Updates